Tg Therapeutics (TGTX) Work In Process (2023 - 2025)

Tg Therapeutics' Work In Process history runs 3 years deep, the most recent figure standing at $121.8 million for Q3 2025.

• In Q3 2025, Work In Process rose 62.47% year-over-year to $121.8 million; the TTM figure through Sep 2025 stood at $121.8 million (up 62.47% YoY), while the FY2024 annual figure was $68.4 million, up 118.84% from the prior year.
• Work In Process was $121.8 million for Q3 2025 at Tg Therapeutics, down from $129.2 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $142.9 million in Q1 2025 to a low of $27.1 million in Q1 2023.
• Historically, Work In Process has averaged $73.5 million across 3 years, with a median of $74.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Work In Process jumped 172.99% in 2024, then surged 62.47% in 2025.
• A 3-year view of Work In Process shows it stood at $31.2 million in 2023, then soared by 118.84% to $68.4 million in 2024, then jumped by 78.16% to $121.8 million in 2025.
• The last three Work In Process figures came in at $121.8 million (Q3 2025), $129.2 million (Q2 2025), and $142.9 million (Q1 2025), per Business Quant data.